Pharmaceuticals in the United States

Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the United States pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

– The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates.

– The US pharmaceuticals market had total revenues of $377.0bn in 2016, representing a compound annual growth rate (CAGR) of 7% between 2012 and 2016.

– High consumption and prices in the United States continues to propel growth in the market. Price inflation, to the discontent of the wider public, has helped this.

– The US is the world’s largest pharmaceuticals market and maintains consistently good growth despite its already highly developed nature and due to the very strong private health sector. The country also has more patents, R&D development facilities, industry employment and major global companies than any other market.

Scope

– Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in the United States

– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the United States

– Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

– Add weight to presentations and pitches by understanding the future growth prospects of the United States pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the United States pharmaceuticals market by value in 2016?

- What will be the size of the United States pharmaceuticals market in 2021?

- What factors are affecting the strength of competition in the United States pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in the United States's pharmaceuticals market?

Companies mentioned

AstraZeneca PLC

Johnson & Johnson

Merck & Co., Inc.

Pfizer Inc.

Table of Contents

Table of Contents

Executive Summary

Market value

Market value forecast

Geography segmentation

Market share

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Geography segmentation

Market share

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

AstraZeneca PLC

Johnson & Johnson

Merck & Co., Inc.

Pfizer Inc.

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine

List of Tables

List of Tables

Table 1: United States pharmaceuticals market value: $ billion, 201216

Table 2: United States pharmaceuticals market geography segmentation: $ billion, 2016

Table 3: United States pharmaceuticals market share: % share, by value, 2016

Table 4: United States pharmaceuticals market value forecast: $ billion, 201621

Table 5: AstraZeneca PLC: key facts

Table 6: AstraZeneca PLC: key financials ($)

Table 7: AstraZeneca PLC: key financial ratios

Table 8: Johnson & Johnson: key facts

Table 9: Johnson & Johnson: key financials ($)

Table 10: Johnson & Johnson: key financial ratios

Table 11: Merck & Co., Inc.: key facts

Table 12: Merck & Co., Inc.: key financials ($)

Table 13: Merck & Co., Inc.: key financial ratios

Table 14: Pfizer Inc.: key facts

Table 15: Pfizer Inc.: key financials ($)

Table 16: Pfizer Inc.: key financial ratios

Table 17: United States size of population (million), 201216

Table 18: United States gdp (constant 2005 prices, $ billion), 201216

Table 19: United States gdp (current prices, $ billion), 201216

Table 20: United States inflation, 201216

Table 21: United States consumer price index (absolute), 201216

Table 22: United States exchange rate, 201215

List of Figures

List of Figures

Figure 1: United States pharmaceuticals market value: $ billion, 201216

Figure 2: United States pharmaceuticals market geography segmentation: % share, by value, 2016

Figure 3: United States pharmaceuticals market share: % share, by value, 2016

Figure 4: United States pharmaceuticals market value forecast: $ billion, 201621

Figure 5: Forces driving competition in the pharmaceuticals market in the United States, 2016

Figure 6: Drivers of buyer power in the pharmaceuticals market in the United States, 2016

Figure 7: Drivers of supplier power in the pharmaceuticals market in the United States, 2016

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2016

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2016

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2016

Figure 11: AstraZeneca PLC: revenues & profitability

Figure 12: AstraZeneca PLC: assets & liabilities

Figure 13: Johnson & Johnson: revenues & profitability

Figure 14: Johnson & Johnson: assets & liabilities

Figure 15: Merck & Co., Inc.: revenues & profitability

Figure 16: Merck & Co., Inc.: assets & liabilities

Figure 17: Pfizer Inc.: revenues & profitability

Figure 18: Pfizer Inc.: assets & liabilities

    Pricing

Quick Buy
Add to basket Request sample pages

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports